动脉瘤多发对动脉瘤性蛛网膜下腔出血后治疗与结局的影响
基于瑞士蛛网膜下腔出血研究2009—2014年数据集,比较多发颅内动脉瘤(MIA)与单发颅内动脉瘤(SIA)的动脉瘤性蛛网膜下腔出血患者结局。1689例连续患者中467例为MIA(患病率26.4%)。MIA组卒中发生率在动脉瘤治疗后和出院时均高于SIA组,但多因素模型OR的95%CI包含1,趋势未达统计学显著;动脉瘤多发是入院至出院期间新发局灶神经功能缺损的独立显著预测因子(OR 1.40,95%CI 1.08-1.81),两组功能结局与总体生存无差异。
要点
- 1689例连续患者中467例为多发颅内动脉瘤,患病率26.4%。
- MIA组治疗后卒中19.3% vs SIA组15.1%,出院时24% vs 21.4%,OR的95%CI包含1,未达统计学显著。
- 动脉瘤多发是入院至出院新发局灶神经功能缺损的独立预测因子(OR 1.40,95%CI 1.08-1.81)。
核心结论
- MIA的aSAH患者短期并发症率高于SIA患者,但这一超额并发症并未使功能结局恶化或降低总体生存。
研究设计与样本
- 使用瑞士蛛网膜下腔出血研究2009—2014年数据集,对aSAH患者中MIA与SIA进行比较,采用描述性分析和多因素回归分析。
- 共纳入1689例连续患者,其中467例为MIA(患病率26.4%)。
- 主要终点为动脉瘤治疗后CT上新发卒中及出院前CT上卒中;次要终点为出院时和1年时的临床与功能状态及总体死亡率。
主要发现
- 卒中发生率MIA组高于SIA组:动脉瘤治疗后19.3% vs 15.1%,出院时24% vs 21.4%,但多因素模型相应OR的95%CI包含1,未达统计学显著。
- 动脉瘤多发是入院至出院期间新发局灶神经功能缺损的独立、统计学显著预测因子(OR 1.40,95%CI 1.08-1.81)。
- MIA组与SIA组在功能结局和总体生存方面均无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One-third of patients with aneurysmal subarachnoid hemorrhage (aSAH) have multiple intracranial aneurysms (MIA). OBJECTIVE: To determine the predictors of outcome in aSAH patients with MIA compared to aSAH patients with a single intracranial aneurysm (SIA). METHODS: The Swiss Study of Subarachnoid Hemorrhage dataset 2009-2014 was used to evaluate outcome in aSAH patients with MIA compared to patients with SIA with the aid of descriptive and multivariate regression analysis. The primary endpoints of this cohort study were presence of new stroke on computed tomography (CT) after aneurysm treatment, and presence of stroke on CT prior to discharge. The secondary endpoints were the clinical and the functional status, and the overall mortality at discharge and at 1 yr. RESULTS: Among 1689 consecutive patients, 467 had MIA (prevalence: 26.4%). The incidence of stroke was higher in the MIA than in the SIA group, both after aneurysm treatment (19.3% vs 15.1%) and at discharge (24% vs 21.4%). However, the 95% confidence interval (CI) for the corresponding odds ratio (OR) in our multivariate model included 1, indicating that the detected trends did not reach statistical significance. As for the secondary endpoints, aneurysm multiplicity was found to be an independent, statistically significant predictor for occurrence of a new focal neurological deficit between admission and discharge (OR 1.40, 95% CI 1.08-1.81). Yet, the MIA and SIA groups did not differ in terms of either functional outcome or overall survival. CONCLUSION: aSAH patients with MIA have a higher short-term morbidity than patients with SIA. This excess morbidity does not worsen the functional outcome or lower overall survival.
引用
- Roethlisberger M, Achermann R, Bawarjan S, et al. Impact of Aneurysm Multiplicity on Treatment and Outcome After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery. 2019. PMID: 30113674. doi:10.1093/neuros/nyy331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。